1. Home
  2. CDTX vs TRS Comparison

CDTX vs TRS Comparison

Compare CDTX & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • TRS
  • Stock Information
  • Founded
  • CDTX 2012
  • TRS 1986
  • Country
  • CDTX United States
  • TRS United States
  • Employees
  • CDTX N/A
  • TRS N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • TRS Industrial Specialties
  • Sector
  • CDTX Health Care
  • TRS Industrials
  • Exchange
  • CDTX Nasdaq
  • TRS Nasdaq
  • Market Cap
  • CDTX 980.1M
  • TRS 1.0B
  • IPO Year
  • CDTX 2015
  • TRS 2007
  • Fundamental
  • Price
  • CDTX $63.31
  • TRS $35.73
  • Analyst Decision
  • CDTX Strong Buy
  • TRS Strong Buy
  • Analyst Count
  • CDTX 11
  • TRS 1
  • Target Price
  • CDTX $52.11
  • TRS $45.00
  • AVG Volume (30 Days)
  • CDTX 659.9K
  • TRS 412.7K
  • Earning Date
  • CDTX 08-07-2025
  • TRS 07-29-2025
  • Dividend Yield
  • CDTX N/A
  • TRS 0.45%
  • EPS Growth
  • CDTX N/A
  • TRS N/A
  • EPS
  • CDTX N/A
  • TRS 0.91
  • Revenue
  • CDTX $302,000.00
  • TRS $973,840,000.00
  • Revenue This Year
  • CDTX N/A
  • TRS $6.37
  • Revenue Next Year
  • CDTX N/A
  • TRS $5.49
  • P/E Ratio
  • CDTX N/A
  • TRS $39.29
  • Revenue Growth
  • CDTX N/A
  • TRS 6.72
  • 52 Week Low
  • CDTX $10.14
  • TRS $19.33
  • 52 Week High
  • CDTX $66.95
  • TRS $36.77
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 70.66
  • TRS 87.71
  • Support Level
  • CDTX $60.71
  • TRS $29.93
  • Resistance Level
  • CDTX $66.95
  • TRS $36.77
  • Average True Range (ATR)
  • CDTX 4.25
  • TRS 1.03
  • MACD
  • CDTX -0.39
  • TRS 0.47
  • Stochastic Oscillator
  • CDTX 79.25
  • TRS 86.49

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About TRS TriMas Corporation

TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.

Share on Social Networks: